Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 14,666 shares at $74.50 ($1.1M) on 2025-11-12, disclosed to the SEC on 2025-11-14.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 7,333 | $546K | 50.0% |
| 2 | $74.50 | 7,333 | $546K | 50.0% |
| Total | $74.50 avg | 14,666 | $1.1M | 100% |
| Filing → |
| PTCT | SELL | 2025-11-25 | $795K | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-07 | $3.4M | — | Filing → |